CardioNet, Inc. Reports Second Quarter 2013 Financial Results

CardioNet, Inc. (BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2013.

Second Quarter 2013 Highlights

• Serviced record patient volume for the second consecutive quarter
• Achieved profitability on an adjusted basis for the first time in four years
• Generated positive adjusted EBITDA of $3.4 million, the highest quarterly EBITDA in four years

  Published: 31 July 2013

  Written by Editor

  Nasdaq   Healthcare   Financial Results   Up on News   Interesting News  

  Read more: CardioNet Inc ( BEAT )

Uroplasty Completes Internal Control Review; Files Form 10-K for Fiscal 2013

No Changes to Previously Reported Results or Financial Statements
Board of Directors Appoints Rob Kill President & Chief Executive Officer
Fiscal 2014 First Quarter Results to be Released on August 1, 2013

Uroplasty, Inc. (UPI), a medical device company that develops, manufactures and markets innovative products to treat voiding dysfunctions, announced today that it has filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2013.  On June 14, 2013, Uroplasty indicated that it had delayed filing the Form 10-K to complete a review of its internal control over financial reporting.  Today, Uroplasty reported that it has completed that review.

CardioNet, Inc. Enters Into Agreement with UnitedHealthcare Insurance Company

Provides Coverage for CardioNet MCOTTM

CardioNet, Inc. (BEAT) (“CardioNet”), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today that the Company has entered into a three-year National Provider Agreement with UnitedHealthcare Insurance Company, covering all of CardioNet’s monitoring modalities, including Mobile Cardiac Outpatient Telemetry (MCOT^TM). The Agreement is effective July 1, 2013 and applies to all UnitedHealthcare affiliated entities, including managed Medicare and managed Medicaid plans. UnitedHealthcare provides coverage to more than 70 million members in the United States.

Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Wisconsin Physicians Services

Uroplasty, Inc. (UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that effective June 1, 2013, Wisconsin Physicians Services (WPS) will begin coverage for Posterior Tibial Nerve Stimulation (PTNS) for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence.

WPS, a Medicare Administrative Contractor, provides medical and drug benefits to approximately 8.7 million Medicare beneficiaries in the States of Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska and Wisconsin.